Jessica Lemaster
Nurse Practitioner · Hazard, KYNPI 1336772342
Payments from drug & device makers
Across 165 payments — averaging $18.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$950
- GSK$422
- Amgen$336
- Pfizer$265
- Novo Nordisk$189
- Shield Therapeutics Inc$162
- plus $804 from 18 others
What the payments were for
- Food & beverage$3,127100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 51 | $950 |
| GSK | 26 | $422 |
| Amgen | 20 | $336 |
| Pfizer | 10 | $265 |
| Novo Nordisk | 10 | $189 |
| Shield Therapeutics Inc | 4 | $162 |
| Bayer | 7 | $120 |
| Ardelyx, Inc. | 5 | $111 |
| Boehringer Ingelheim | 7 | $107 |
| Lilly USA, LLC | 5 | $95 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $47 |
| Exact Sciences | 3 | $45 |
| AstraZeneca | 2 | $36 |
| Novartis | 2 | $33 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $33 |
| Smith+Nephew | 1 | $30 |
| Dexcom, Inc. | 1 | $28 |
| Astellas Pharma US Inc | 1 | $25 |
| Alkermes, Inc. | 1 | $19 |
| Eisai Inc. | 1 | $18 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Athena Bioscience, LLC | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PAXLOVID$114
How this compares
$3,127 in reported general payments places this provider in the 85th percentile of 1,918 nurse practitioner providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 75 | $70,855 |
| MounjaroTirzepatide | 62 | $69,716 |
| JardianceEmpagliflozin | 41 | $41,751 |
| EliquisApixaban | 38 | $30,658 |
| TrulicityDulaglutide | 25 | $30,353 |
| FarxigaDapagliflozin Propanediol | 31 | $27,492 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 32 | $21,593 |
| Repatha SureclickEvolocumab | 20 | $10,691 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 12 | $7,607 |
| SymbicortBudesonide/Formoterol Fumarate | 14 | $6,707 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 440 | $5,893 |
| BreynaBudesonide/Formoterol Fumarate | 26 | $4,804 |
| EntrestoSacubitril/Valsartan | 12 | $4,050 |
| Insulin Lispro Protamine MixInsulin Lispro Protamin/Lispro | 23 | $3,594 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 121 | $3,559 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humulin N | $95 | $101,751105 claims |
| Novo NordiskOzempic, Levemir | $189 | $72,12687 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $36 | $41,80657 claims |
| Boehringer IngelheimJardiance | $107 | $41,75141 claims |
| PfizerEliquis | $265 | $30,65838 claims |
| GSKTrelegy Ellipta | $422 | $21,59332 claims |
| NovartisEntresto | $33 | $4,05012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,918 nurse practitioner providers in Kentucky.
Other nurse practitioner in Hazard
- Rachael BradfordLexington$447K
- Tara MuddLouisville$243K
- Lee HaasLouisville$95K
- Ashley KnableLouisville$86K
- Christina BenningerLouisville$81K
- Courtney BowlingCampbellsville$47K
- Rebecca BraunerLouisville$40K
- Scott SeitzWinchester$34K
- Kristen KreinestEdgewood$34K
- Lillian ArgentEdgewood$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.